Dr. Gina Graziani

Biosafety Risk Analyst (lead SARS-CoV-2 analyst)

I am a PhD-trained immunologist currently working as the lead SARS-CoV-2 risk analyst for the Biosafety Risk Assessment team in the Centre for Biosecurity.  I am also involved in risk assessments for other biological agents. Previous to this, I was a vaccine regulator (quality group)  for Health Canada.  I have many years of experience in clinical and basic immunology research, especially in the field of HIV.  

Key publications

  • SARS-CoV-2 risk assessment
  • Delta variant of concern risk assessment
  • SARS-CoV-2 Pathogen Safety Datasheet
  • SARS-CoV-2 Biosafety Advisory
  • various departmental presentations: 
    • highlights of the SARS-CoV-2 risk assessement
    • SARS-CoV-2 variants
    • SARS-CoV-2 vaccines
  • risk assessments for other biological agents
  • risk assessements for human vaccines and monoclonal antibodies